Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T39376 |
Thalidomide-O-C8-NH2
Thalidomide-O-C8-NH2 |
Others | Others |
Thalidomide-O-C8-NH2 is a chemically synthesized conjugate that combines a cereblon ligand derived from Thalidomide with a linker utilized in PROTAC technology. It functions as an E3 ligase ligand-linker conjugate. | |||
T40261 |
Thalidomide-O-C8-NH2 hydrochloride
Thalidomide-O-C8-NH2 hydrochloride |
Others | Others |
Thalidomide-O-C8-NH2 hydrochloride is a chemical compound consisting of a synthesized E3 ligase ligand-linker conjugate. This compound incorporates a cereblon ligand derived from Thalidomide, as well as a linker employed in PROTAC technology. | |||
T18817 |
Thalidomide-O-amido-C8-NH2 hydrochloride
Thalidomide-O-amido-C8-NH2 hydrochloride (1950635-15-0 free base) |
Others | Others |
Thalidomide-O-amido-C8-NH2 hydrochloride is a synthetic conjugate of an E3 ligase ligand-linker, which combines a cereblon ligand derived from Thalidomide and a linker. It can be utilized in the synthesis of PROTACs[1]. | |||
T17819 |
Thalidomide-O-amido-C8-NH2
E3 Ligase Ligand-Linker Conjugates 20,Cereblon Ligand-Linker Conjugates 2 |
Others | Others |
Thalidomide-O-amido-C8-NH2 (Cereblon Ligand-Linker Conjugates 2) is a synthesized E3 ligase ligand-linker conjugate comprising a Thalidomide-based cereblon ligand and a linker. This compound is useful in the synthesis of PROTACs, as per reference [1]. |